LAVA Therapeutics Q3 EPS $(0.34) Down From $0.04 YoY
Author: Benzinga Newsdesk | November 16, 2023 08:09am
LAVA Therapeutics (NASDAQ:LVTX) reported quarterly losses of $(0.34) per share. This is a 950 percent decrease over earnings of $0.04 per share from the same period last year.